Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 2
2007 3
2008 2
2009 2
2010 3
2011 2
2012 2
2013 6
2014 8
2015 2
2016 5
2017 3
2018 10
2019 5
2020 5
2021 5
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS. Gil-Jimenez A, et al. Among authors: mengual l. Eur Urol. 2023 Apr;83(4):313-317. doi: 10.1016/j.eururo.2022.07.023. Epub 2022 Aug 11. Eur Urol. 2023. PMID: 35965206
MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. Catto JW, et al. Among authors: mengual l. Eur Urol. 2011 May;59(5):671-81. doi: 10.1016/j.eururo.2011.01.044. Epub 2011 Feb 1. Eur Urol. 2011. PMID: 21296484 Review.
Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma.
Roldán FL, Izquierdo L, Ingelmo-Torres M, Lozano JJ, Carrasco R, Cuñado A, Reig O, Mengual L, Alcaraz A. Roldán FL, et al. Among authors: mengual l. Cancers (Basel). 2022 Aug 1;14(15):3754. doi: 10.3390/cancers14153754. Cancers (Basel). 2022. PMID: 35954418 Free PMC article.
Assessment of aggressive bladder cancer mutations in plasma cell-free DNA.
Carrasco R, Ingelmo-Torres M, Oriola J, Roldán FL, Rodríguez-Carunchio L, Herranz S, Mellado B, Alcaraz A, Izquierdo L, Mengual L. Carrasco R, et al. Among authors: mengual l. Front Oncol. 2023 Nov 30;13:1270962. doi: 10.3389/fonc.2023.1270962. eCollection 2023. Front Oncol. 2023. PMID: 38098507 Free PMC article.
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
Galesloot TE, Grotenhuis AJ, Kolev D, Aben KK, Bryan RT, Catto JWF, Cheng KK, Conroy S, Dyrskjøt L, Fleshner NE, James ND, Lamy P, Lindskrog SV, Malats N, Mengual L, Verhaegh G, Zeegers MP, Kiemeney LALM, Vermeulen SH. Galesloot TE, et al. Among authors: mengual l. Eur Urol Oncol. 2022 Feb;5(1):70-83. doi: 10.1016/j.euo.2021.07.001. Epub 2021 Aug 2. Eur Urol Oncol. 2022. PMID: 34353775 Free article.
70 results